Last reviewed · How we verify
NCT06553300
Auto Transplantation of Wisdom Teeth
NA trial testing Autotransplantation with PRF in Autotransplantation of Wisdom Teeth in 20 participants. Currently enrolling.
31 October 2024
Quick facts
| Lead sponsor | Cleveland Dental Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 January 2024 |
| Primary completion | 31 October 2024 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Autotransplantation with PRF
- Autotransplatation Only
Conditions studied
- Autotransplantation of Wisdom Teeth — all drugs for Autotransplantation of Wisdom Teeth →
- Patelet Rich Fibrin — all drugs for Patelet Rich Fibrin →
Sponsor
Cleveland Dental Institute
Who can join
Adults 18 to 50, any sex, with Autotransplantation of Wisdom Teeth or Patelet Rich Fibrin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Autotransplantation emerges as a viable alternative to tooth extraction and prosthetic restoration when conventional endodontic treatments are unfeasible or contraindicated. The success of autotransplantation is influenced by diverse factors, including root development stage, tooth morphology, surgical technique, extraoral duration, recipient socket shape, recipient bed vascularity, and periodontal ligament cell vitality. Preserving periodontal ligament quality and achieving tissue adaptation are pivotal for successful tooth transplantation. Successful donor tooth replacement is influenced by variables like fitting attempts, alveolus-root distance, extra-alveolar time, surgical skill, and extraction trauma intensity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06553300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cleveland Dental Institute trials
Trials by the same sponsor.
- NCT06564987 — Risk of Nerve Damage After Administration of Local Anesthesia · Phase 1 · recruiting
- NCT06538233 — Pain After Buffered Vs Non Buffered Articaine · Phase 2 · recruiting
- NCT06528574 — Postoperative Pain After Activation of Irrigant · NA · recruiting
- NCT06526572 — Pain Measured by NRS and EEG in Acute Pulpitis · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06553300 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cleveland Dental Institute
- Last refreshed: 14 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06553300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing